R2* derived from multi-echo Dixon imaging is a potential biomarker to differentiate malignant from benign FFLs. R2* value of malignant FLLs was significantly higher than that of the benign FLLs. The multi-echo Dixon sequence is easy to perform and required only a single breath-hold of 16 s to image the entire liver, which holds a good potential for clinical application.
This abstract and the presentation materials are available to members only; a login is required.